Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Neutralization
Human
IgG1, kappa
S2P6
Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Neutralization
Human
IgG1, kappa
S41
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Neutralization, IF
Human
IgG1, kappa
D12
Human betacoronavirus 2c EMC/2012
ELISA, Neutralization
Human
IgG1, kappa
4C2
Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG
3A1
SARS-CoV-2
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
BA7535
SARS-CoV-2
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1
BA7208
SARS-CoV-2 (2019-nCoV), Mers-CoV
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
CC99.103
SARS-CoV-2 (2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
SARS-CoV-2(2019-nCoV)
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Human
IgG1-kappa
XG005M